ArticleBMC anesthesiology2025
Effects of intravenous morphine and lidocaine on bacterial growth.
Article in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfection prevention and control remain critical challenges in the ICU. Morphine, a frequently used opioid for postoperative pain management, may indirectly promote infections, whereas lidocaine might have protective effects. However, data regarding the direct influence of morphine and lidocaine, at concentrations within the range of plasma concentrations, on common ICU bacterial strains are lacking. This is the first study to investigate the direct effects of morphine and lidocaine at plasma concentrations corresponding to possible clinical settings, as seen in multimodal analgesia regimens, on bacterial growth using microbiological assays and transmission electron microscopy.
methodsMorphine (1000 ng/ml, 2000 ng/ml) and lidocaine (4 µg/ml, 10 µg/ml) were placed in contact with standard strains of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus and tested using diffusion method, broth dilution method, and time-kill assay. Additionally, E. coli, P. aeruginosa and S. aureus were exposed to lidocaine 10 µg/ml and examined via transmission electron microscopy.
resultsMorphine and lidocaine exhibited neither stimulatory nor inhibitory effects on bacterial growth, regardless of concentration, volume, or exposure time in microbiological testing. In contrast, transmission electron microscopy revealed that lidocaine exposure altered bacterial ultrastructure, causing significant cell wall disorganization and rupture, alterations in cytoplasmic and nucleolar structure, and the appearance of "ghost cells", indicative of cell lysis.
conclusionsAt plasma concentrations, morphine and lidocaine do not directly affect bacterial growth in vitro microbiological laboratory testing. Lidocaine on the other hand, in higher plasma concentrations, disrupts bacterial ultrastructure. Further studies are needed to investigate the significance and clinical impact of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.